We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAMO:NASDAQMassimo Group Analysis

Data as of 2026-05-30 - not real-time

$0.97

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Massimo Group (MAMO) is trading at $0.97, a steep discount to its 52‑week high of $5.59 and reflecting a bearish market trend (trend_direction: bearish, macd_signal: bullish but weak). The stock’s 30‑day volatility of 55.3% and a staggering max drawdown of –83.6% underscore extreme price instability, while a beta of 1.38 (computed) signals heightened sensitivity to market swings.
Fundamentally, revenue has slipped 14.7% year‑over‑year to $69.6 M, operating margin is negative (‑8.2%), and debt‑to‑equity sits at an alarming 39.2, indicating leverage pressure despite modest cash reserves of $4.1 M. The company’s price‑to‑book ratio of 1.78 and a P/E of 13.9 suggest the market values the stock above its book value but not excessively overvalued.
Recent product announcements – the Sentinel 770 HVAC UTV targeting roughly $10 M of incremental 2026 revenue – provide a clear growth catalyst, yet the current financial strain and high risk profile temper optimism.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical trend with RSI 43.7 and MACD near‑neutral bullish signal
  • Extreme price volatility (55% 30‑day) and large max drawdown (-83.6%)
  • Current negative operating margin and high leverage (debt‑to‑equity 39.2)

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Pending revenue boost from Sentinel 770 HVAC launch (~$10 M potential)
  • Improving cash flow (operating cash flow $1.86 M) against modest cash balance
  • Still‑elevated beta (1.38) and sector cyclicality risk

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic product expansion into climate‑controlled UTVs
  • Reasonable valuation relative to book (price/book 1.78) and P/E 13.9
  • Long‑term upside potential if operating efficiency improves and debt is restructured

Key Metrics & Analysis

Financial Health

Revenue Growth-14.70%
Profit Margin3.72%
P/E Ratio13.9
ROE12.17%
ROA5.03%
Debt/Equity39.18
P/B Ratio1.8
Op. Cash Flow$1.9M
Free Cash Flow$4.8M

Technical Analysis

TrendBearish
RSI43.7
Support$0.95
Resistance$1.05
MA 20$0.99
MA 50$1.01
MA 200$2.41
MACDBullish
VolumeIncreasing
Fear & Greed Index94.07

Valuation

Fair Value$1.42
GradeFair
TypeBlend

Risk Assessment

Beta1.38
Volatility55.26%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.